Work

Peripheral Neuropathy Associated With Ipilimumab: A Report of 2 Cases

Year: 2015
Type: article
Study design: Case Report
Abstract: Ipilimumab, a monoclonal antibody targeting human cytotoxic T-lymphocyte-associated antigen 4, was approved by the FDA and European Medicines Agency for the treatment of metastatic melanoma. Immune-related adverse effects can occur with the use of this agent, but peripheral nervous system problems are rare. We report 2 cases of ipilimumab-induced polyneuropathy.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W2329842261
FWCI: 3.692
Cites: 11
Cited by: 58
Related to: 10